Clinical trials
Enrolling by invitation Phase 3 trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 2 |
| UCB Biopharma SRL | 2 |
| United Therapeutics | 2 |
| Viatris Innovation GmbH | 2 |
| ACADIA Pharmaceuticals Inc. | 1 |
| Alnylam Pharmaceuticals | 1 |
| Asan Medical Center | 1 |
| AstraZeneca | 1 |
| BioCryst Pharmaceuticals | 1 |
| Celldex Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Connective Tissue Diseases | 3 |
| Lupus Erythematosus, Systemic | 3 |
| Angioedemas, Hereditary | 2 |
| Hypertension | 2 |
| Immune System Diseases | 2 |
| Amyloidosis | 1 |
| Autoimmune Diseases | 1 |
| Cardiomyopathies | 1 |
| Cardiovascular Diseases | 1 |
| Chronic Urticaria | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.